<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565006</url>
  </required_header>
  <id_info>
    <org_study_id>0859-012</org_study_id>
    <secondary_id>2007_656</secondary_id>
    <nct_id>NCT00565006</nct_id>
  </id_info>
  <brief_title>A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      This study will investigate the influence of MK0859 on ambulatory blood pressure, and how&#xD;
      safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific&#xD;
      protocol information is in progress and not publicly available at this time. (Full&#xD;
      information is available to trial participants).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <primary_completion_date type="Actual">September 2006</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">22</enrollment>
  <condition>Ambulatory Blood Pressure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MK0859</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  You are between the ages of 45-75&#xD;
&#xD;
          -  You are a man or non-pregnant woman&#xD;
&#xD;
          -  You agree to not eat or drink fruit or fruit juices (orange, apple or grapefruit) for&#xD;
             2 weeks before starting study medication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  You have smoked or used other nicotine-containing products (chewing tobacco) within&#xD;
             the last 6 months&#xD;
&#xD;
          -  You have used St. John's Wort or any products that include it within the last 2 weeks&#xD;
&#xD;
          -  You have used herbal, organic, dietary or nutritional remedies within the last 2 weeks&#xD;
&#xD;
          -  You have a history of drug allergies (anaphylaxis, angioedema)&#xD;
&#xD;
          -  You have taken an investigational drug in another clinical trial within the last 4&#xD;
             weeks&#xD;
&#xD;
          -  You have a history of cardiovascular disease including hypertension (high blood&#xD;
             pressure)&#xD;
&#xD;
          -  You have a history of renal disease&#xD;
&#xD;
          -  You have a history of gall bladder disease or have had abnormal liver function tests&#xD;
&#xD;
          -  You have a history of drug or alcohol abuse&#xD;
&#xD;
          -  You drink more than 6 cups of caffeinated beverages a day (coffee, tea or cola)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>November 27, 2007</study_first_submitted>
  <study_first_submitted_qc>November 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2007</study_first_posted>
  <last_update_submitted>February 25, 2015</last_update_submitted>
  <last_update_submitted_qc>February 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anacetrapib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

